Authors:
CESKA R
HORINEK A
SOBRA J
WEISGRABER KH
INNERARITY T
SLEZKA V
Citation: R. Ceska et al., FDB-100 - DIAGNOSIS, LABORATORY AND CLINICAL FINDINGS, POSSIBILITIES OF TREATMENT - EXPERIENCE FROM HOMOZYGOUS AND HETEROZYGOUS PATIENTS, Atherosclerosis, 134(1-2), 1997, pp. 110-111
Authors:
OCKNER RK
BASS NM
YAMANAKA S
INNERARITY T
Citation: Rk. Ockner et al., HEPATOCELLULAR DYSPLASIA AND CARCINOMA IN APOBEC-1 TRANSGENIC MICE - INCREASED EXPRESSION OF EXTRAMITOCHONDRIAL FATTY-ACID OXIDATION, Hepatology, 24(4), 1996, pp. 852-852
Authors:
RAFFAI R
MAURICE R
WEISGRABER K
INNERARITY T
WANG XB
MACKENZIE R
HIRAMA T
WATSON D
RASSART E
MILNE R
Citation: R. Raffai et al., MOLECULAR CHARACTERIZATION OF 2 MONOCLONAL-ANTIBODIES SPECIFIC FOR THE LDL RECEPTOR-BINDING SITE OF HUMAN APOLIPOPROTEIN-E, Journal of lipid research, 36(9), 1995, pp. 1905-1918
Authors:
BUCALA R
MITCHELL R
ARNOLD K
INNERARITY T
VLASSARA H
CERAMI A
Citation: R. Bucala et al., IDENTIFICATION OF THE MAJOR SITE OF APOLIPOPROTEIN-B MODIFICATION BY ADVANCED GLYCOSYLATION END-PRODUCTS BLOCKING UPTAKE BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR, The Journal of biological chemistry, 270(18), 1995, pp. 10828-10832